Navigation Links
BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences

JERUSALEM--(BUSINESS WIRE)--May 17, 2007 - BioLineRx Ltd. (TASE: BLRX), Israel's leading drug development company, announced today that abstracts containing data from its successfully completed phase I clinical trails of BL-1020, first in class GABA-enhanced antipsychotic for the treatment of schizophrenia, have been accepted for poster presentations at three leading scientific conferences. The data will be presented at the following conferences:

-- Society of Biological Psychiatry Annual Convention, May 17-19 (San Diego)

-- American Psychiatric Association Annual Meeting, May 19-24 (San Diego)

-- New Clinical Drug Evaluation Unit Annual (NCDEU) Meeting, June 11-14 (Boca Raton)

The abstract which has been selected for these poster presentations describes the results of a Phase I, randomized, placebo-controlled double blinded, single dose-escalation study to evaluate the safety and determine the pharmacokinetic profile of BL-1020, first in class GABA-enhanced antipsychotic for the treatment of schizophrenia.

"We are very pleased that these important data regarding the Phase I trials of BL-1020 are being presented at these three major psychiatric conferences. The Phase I studies support our product profile of a highly efficacious antipsychotic devoid of extrapyramidal symptoms or metabolic side effects," commented Morris Laster, chief executive officer of BioLineRx. "We continue to believe that the compound holds great promise for the treatment of schizophrenia, which currently poses an intractable medical problem for physicians and patients. We very much look forward to the initiation of the Phase II trial in the second quarter of 2007."

About BL-1020

BL-1020 is an orally available GABA enhanced antipsychotic clinical candidate for the treatment of schizophrenia. Data from preclinical and phase I studies demonstrated that the compound may retain the efficacy of currently
'"/>




Page: 1 2 3

Related medicine technology :

1. BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference
2. BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
Post Your Comments:
(Date:8/1/2014)... 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Deep Research ... and "2014 Deep Research Report on Global and ... research database. Photo - ... Report on Global and China Potassium Nitrate  Industry" ... China and Global Potassium ...
(Date:7/31/2014)... July 31, 2014 STAAR Surgical Company (NASDAQ: ... marketer of implantable lenses and delivery systems for the ... July 4, 2014 of $20.0 million, a 10% increase ... 2013. On a constant currency basis, revenues grew 11% ... second quarter of 2013.  The effect of foreign currency ...
(Date:7/31/2014)... Calif., July 31, 2014 Xencor Inc. ... company developing engineered monoclonal antibodies for the treatment ... cancer, today reported financial results for the second ... of recent business highlights. "In the ... American Thoracic Society 2014 International Conference (ATS) demonstrating ...
Breaking Medicine Technology:Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 2Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 3Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 4Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31Xencor Reports Second Quarter 2014 Financial Results 2
(Date:8/1/2014)... Tara Haelle HealthDay ... A home-packed lunch isn,t necessarily healthier than school cafeteria fare, ... just 27 percent of the lunches third and fourth graders ... Program (NSLP) standards. , , "Our findings are similar to ... the world, which have found that high-calorie packaged foods and ...
(Date:8/1/2014)... [Brown University] New research shows that people who ... incarcerated have a 16-percent greater risk of experiencing poor ... family member sent to prison. The finding, which accounted ... nation,s high rate of imprisonment may be independently imparting ... , "These people were children when this happened, and ...
(Date:8/1/2014)... Fresh from Las Vegas market, the team at ... exciting products. With the 2014 Holiday season just around the ... new products. There have already been some exciting new releases, ... brands like Cozzia and Inada will be making a big ... takes place two times a year and is a great ...
(Date:8/1/2014)... 2014 The Multiple System Atrophy Coalition, a ... caregivers and families affected by the neurological disorder Multiple System ... La Coste, TX to its Board of Directors. , Sharon ... Eric Sutton. He was diagnosed officially with MSA in 2010 ... his family. Like many others with this rare disorder it ...
(Date:8/1/2014)... Fitness is something most people can add to ... the block to biking ten or more miles, adding daily ... throughout the year. The Forbes Living talk show ... feature special guests, tips to get started and cool products ... will air on most popular cable television networks. , ...
Breaking Medicine News(10 mins):Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 2Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 3Health News:Jailed family member increases risks for kids' adult health 2Health News:Jailed family member increases risks for kids' adult health 3Health News:A Recap of the 2014 Summer Las Vegas Furniture Market by Emassagechair.com 2Health News:A Recap of the 2014 Summer Las Vegas Furniture Market by Emassagechair.com 3Health News:Sharon Kramer Sutton, 30 Year Veteran of Rare Disease Advocacy, Appointed to Multiple System Atrophy Coalition Board of Directors 2Health News:Sharon Kramer Sutton, 30 Year Veteran of Rare Disease Advocacy, Appointed to Multiple System Atrophy Coalition Board of Directors 3Health News:Forbes Living to Air Fitness Forward Series 2
... This release is available in ... scientist Dr. Timothy Geary received a $1-million grant today ... derived from African biodiversity. Grand Challenges Canada, Canada,s ... Research and the Bill & Melinda Gates Foundation have ...
... University of Michigan Cardiovascular Center and the University of Pittsburgh ... of heart devices for the large and growing group of ... Lung and Blood Institute and HeartWare International, a maker of ... access to these devices that support the circulation of patients ...
... breast cancer medication, may reduce an individual,s risk of death ... a peer-reviewed journal of the American Cancer Society, the study ... lung cancer and that estrogen levels play a role in ... menopausal hormone therapy increases women,s risk of dying from lung ...
... to survive and thrive in its hiding spot within the human ... HIV remains such a formidable foe after three decades of research ... it also offers scientists a new, unexpected way to try ... University of Rochester Medical Center and Emory University was published Dec. ...
... at Johns Hopkins have deciphered the genetic code for a ... The work, described online in the Jan. 20 issue of ... certain coding "mistakes" live twice as long as those without ... is that each patient with this kind of rare cancer ...
... HealthDay Reporter , FRIDAY, Jan. 21 (HealthDay News) ... Drug Administration approve a new chemical that can highlight the ... help doctors diagnose the neurodegenerative disease, experts said Friday. ... 0 to recommend approval of the imaging agent, known as ...
Cached Medicine News:Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 2Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 3Health News:Study examines earlier use of heart pumps in growing group of heart failure patients 2Health News:Study examines earlier use of heart pumps in growing group of heart failure patients 3Health News:Anti-estrogen medication reduces risk of dying from lung cancer 2Health News:Unexpected find opens up new front in effort to stop HIV 2Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 2Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 3Health News:Alzheimer's Scan Might Help Spot Disease 2Health News:Alzheimer's Scan Might Help Spot Disease 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: